Supply Chain

The Food and Drug Administration is monitoring dozens of medical devices produced in Puerto Rico for potential shortage risks, according to FDA Commissioner Scott Gottlieb, MD.

Here are the five latest drugs and medical devices approved by the Food and Drug Administration in the past week.

Dr. Reddy's Laboratories recalled more than 500,000 bottles of 10-milligram famotidine tablets Oct. 3, reports Business Standard.

Ten to 20 percent of pharmaceutical companies are shifting their advertising focus away from digital media and instead directing it toward the point-of-care, according to a recent analysis conducted by ZS Associates.

Here are seven articles Becker's Hospital Review published in the last week, highlighting Baxter's temporary shortage of small saline bags, Amneal Pharmaceutical's merger with Impax Laboratories and more.

The Food and Drug Administration on Wednesday approved Kite Pharma's gene therapy, Yescarta, which uses patients' genetically modified immune cells to fight cancer.

Novartis will eliminate 450 U.S. jobs over the next two years during the gradual closure of its generic drug manufacturing plant in Broomfield, Colo., reports Reuters.

The No. 1 attribute providers ranked as important when purchasing a medical device is consistent outcomes, according to a Vennli survey.

The price of injectable brand-name cancer drugs are rising at a pace faster than inflation, according to a study published in the Journal of Clinical Oncology.

Minnetonka, Minn.-based UnitedHealth Group sees Amazon, who is reportedly exploring entering the pharmaceutical business, as a potential partner rather than a competitor, reports The Star Tribune.